Interspecies transmission, adaptation to humans and pathogenicity of animal influenza viruses;Transmission inter-espèces, adaptation à l'homme et pathogénicité des virus influenza d'origine animale

Pathologie Biologie

Volumn 58, Issue 2, 2010, Pages

  Munier, S ^a   Moisy, D ^a   Marc, D ^b   Naffakh, N ^a  

^a Sorbonne Paris Cité   (France)

^b UR1282   (France)

Author keywords

Host specificity; Influenza viruses; Interspecies transmission; Pandemic; Pathogenesis; Zoonosis

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; PROTEIN PB1 F2; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ADAPTATION; ARTICLE; AVIAN INFLUENZA VIRUS; BIRD DISEASE; GENE MUTATION; GENE REPLICATION; GENETIC REASSORTMENT; GENETIC VARIABILITY; HOST RANGE; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NONHUMAN; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ZOONOSIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BIRDS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; HUMANS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; RECEPTORS, VIRUS; RIBONUCLEOPROTEINS; SPECIES SPECIFICITY; SWINE; SWINE DISEASES; VIRAL PROTEINS; VIRAL TROPISM; VIRULENCE; ZOONOSES;

EID: 77952021579     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2010.01.012     Document Type: Article

References (97)

1. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459(7249):931-939.
2. Données OMS du 30/12/2009: http://www.who.int/csr/disease/avian_influenza/en.
3. Iuliano A.D., Reed C., Guh A., Desai M., Dee D.L., Kutty P., et al. Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis 2009, 49(12):1811-1820.
4. Presanis A.M., De Angelis D., Hagy A., Reed C., Riley S., Cooper B.S., et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009, 6(12):e1000207.
5. Webb S.A., Pettila V., Seppelt I., Bellomo R., Bailey M., Cooper D.J., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361(20):1925-1934.
6. Yen H.L., Webster R.G. Pandemic influenza as a current threat. Curr Top Microbiol Immunol 2009, 333:3-24.
7. Munster V.J., Fouchier R.A. Avian influenza virus: of virus and bird ecology. Vaccine 2009, 27(45):6340-6344.
8. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56(1):152-179.
9. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351(9101):472-477.
10. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279(5349):393-396.
11. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353(13):1374-1385.
12. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371(9622):1464-1475.
13. Brown I.H. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 2000, 74(1-2):29-46.
14. Olsen C.W., Brammer L., Easterday B.C., Arden N., Belay E., Baker I., et al. Serologic evidence of H1 swine Influenza virus infection in swine farm residents and employees. Emerg Infect Dis 2002, 8(8):814-819.
15. Myers K.P., Olsen C.W., Gray G.C. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007, 44(8):1084-1088.
16. Hodder R.A., Gaydos J.C., Allen R.G., Top F.H., Nowosiwsky T., Russell P.K. Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis 1977, 136(Suppl.):S369-S375.
17. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
18. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459(7250):1122-1125.
19. Vincent A.L., Ma W., Lager K.M., Janke B.H., Richt J.A. Swine influenza viruses a North American perspective. Adv Virus Res 2008, 72:127-154.
20. Horimoto T., Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005, 3(8):591-600.
21. Smith G.J., Bahl J., Vijaykrishna D., Zhang J., Poon L.L., Chen H., et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 2009, 106(28):11709-11712.
22. Reid A.H., Taubenberger J.K., Fanning T.G. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol 2004, 2(11):909-914.
23. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005, 310(5745):77-80.
24. Nicholls J.M., Chan R.W., Russell R.J., Air G.M., Peiris J.S. Evolving complexities of influenza virus and its receptors. Trends Microbiol 2008, 16(4):149-157.
25. Wagner R., Matrosovich M., Klenk H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002, 12(3):159-166.
26. Rogers G.N., Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127(2):361-373.
27. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 2000, 74(18):8502-8512.
28. Kobasa D., Takada A., Shinya K., Hatta M., Halfmann P., Theriault S., et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004, 431(7009):703-707.
29. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998, 72(9):7367-7373.
30. Connor R.J., Kawaoka Y., Webster R.G., Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205(1):17-23.
31. Vines A., Wells K., Matrosovich M., Castrucci M.R., Ito T., Kawaoka Y. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol 1998, 72(9):7626-7631.
32. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006, 355(5):1143-1155.
33. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007, 315(5812):655-659.
34. Childs R.A., Palma A.S., Wharton S., Matrosovich T., Liu Y., Chai W., et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009, virus determined by carbohydrate microarray. Nat Biotechnol 2009, 27(9):797-799.
35. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009, 325(5939):484-487.
36. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 1999, 73(2):1146-1155.
37. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440(7083):435-436.
38. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., et al. H5N1 virus attachment to lower respiratory tract. Science 2006, 312(5772):399.
39. Nicholls J.M., Chan M.C., Chan W.Y., Wong H.K., Cheung C.Y., Kwong D.L., et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007, 13(2):147-149.
40. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312(5772):404-410.
41. Gambaryan A., Tuzikov A., Pazynina G., Bovin N., Balish A., Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006, 344(2):432-438.
42. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006, 444(7117):378-382.
43. Auewarakul P., Suptawiwat O., Kongchanagul A., Sangma C., Suzuki Y., Ungchusak K., et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007, 81(18):9950-9955.
44. Li K.S., Guan Y., Wang J., Smith G.J., Xu K.M., Duan L., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004, 430(6996):209-213.
45. Banks J., Speidel E.S., Moore E., Plowright L., Piccirillo A., Capua I., et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol 2001, 146(5):963-973.
46. Giannecchini S., Campitelli L., Calzoletti L., De Marco M.A., Azzi A., Donatelli I. Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. J Gen virol 2006, 87(Pt 1):171-175.
47. Matsuoka Y., Swayne D.E., Thomas C., Rameix-Welti M.A., Naffakh N., Warnes C., et al. Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J Virol 2009, 83(9):4704-4708.
48. Munier S., Larcher T., Cormier-Aline F., Soubieux D., Su B., Guigand L., et al. Increased virulence for chickens of a genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase. J Virol 2010, 84(2):940-952.
49. Zhou H., Yu Z., Hu Y., Tu J., Zou W., Peng Y., et al. The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One 2009, 4(7):e6277.
50. Lin Y.P., Wharton S.A., Martin J., Skehel J.J., Wiley D.C., Steinhauer D.A. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 1997, 233(2):402-410.
51. Takahashi T., Suzuki Y., Nishinaka D., Kawase N., Kobayashi Y., Hidari K.I., et al. Duck and human pandemic influenza A viruses retain sialidase activity under low pH conditions. J Biochem 2001, 130(2):279-283.
52. Neumann G., Brownlee G.G., Fodor E., Kawaoka Y. Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004, 283:121-143.
53. Naffakh N., Tomoiu A., Rameix-Welti M.A., van der Werf S. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol 2008, 62:403-424.
54. Massin P., van der Werf S., Naffakh N. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol 2001, 75(11):5398-5404.
55. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293(5536):1840-1842.
56. Hatta M., Hatta Y., Kim J.H., Watanabe S., Shinya K., Nguyen T., et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 2007, 3(10):1374-1379.
57. Steel J., Lowen A.C., Mubareka S., Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 2009, 5(1):e1000252.
58. Tarendeau F., Crepin T., Guilligay D., Ruigrok R.W., Cusack S., Hart D.J. Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit. PLoS Pathog 2008, 4(8):e1000136.
59. Rameix-Welti M.A., Tomoiu A., Dos Santos Afonso E., van der Werf S., Naffakh N. Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection. J Virol 2009, 83(3):1320-1331.
60. Mehle A., Doudna J.A. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 2008, 4(2):111-122.
61. Mehle A., Doudna J.A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A 2009, 106(50):21312-21316.
62. Tarendeau F., Boudet J., Guilligay D., Mas P.J., Bougault C.M., Boulo S., et al. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol 2007, 14(3):229-233.
63. Resa-Infante P., Jorba N., Zamarreno N., Fernandez Y., Juarez S., Ortin J. The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PLoS One 2008, 3(12):e3904.
64. Gabriel G., Herwig A., Klenk H.D. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog 2008, 4(2):e11.
65. Mayer D., Molawi K., Martinez-Sobrido L., Ghanem A., Thomas S., Baginsky S., et al. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 2007, 6(2):672-682.
66. Jorba N., Juarez S., Torreira E., Gastaminza P., Zamarreno N., Albar J.P., et al. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 2008, 8(10):2077-2088.
67. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267.
68. Konig R., Stertz S., Zhou Y., Inoue A., Heinrich Hoffmann H., Bhattacharyya S., et al. Human host factors required for influenza virus replication. Nature 2010, 463(7282):813-817.
69. Naito T., Kiyasu Y., Sugiyama K., Kimura A., Nakano R., Matsukage A., et al. An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc Natl Acad Sci U S A 2007, 104(46):18235-18240.
70. Fouchier R.A., Schneeberger P.M., Rozendaal F.W., Broekman J.M., Kemink S.A., Munster V., et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004, 101(5):1356-1361.
71. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5(5):439-449.
72. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008, 89(Pt 10):2359-2376.
73. Obenauer J.C., Denson J., Mehta P.K., Su X., Mukatira S., Finkelstein D.B., et al. Large-scale sequence analysis of avian influenza isolates. Science 2006, 311(5767):1576-1580.
74. Jiao P., Tian G., Li Y., Deng G., Jiang Y., Liu C., et al. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 2008, 82(3):1146-1154.
75. Min J.Y., Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 2006, 103(18):7100-7105.
76. Donelan N.R., Basler C.F., Garcia-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 2003, 77(24):13257-13266.
77. Cauthen A.N., Swayne D.E., Sekellick M.J., Marcus P.I., Suarez D.L. Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 2007, 81(4):1838-1847.
78. Kochs G., Koerner I., Thiel L., Kothlow S., Kaspers B., Ruggli N., et al. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 2007, 88(Pt 5):1403-1409.
79. Seo S.H., Hoffmann E., Webster R.G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002, 8(9):950-954.
80. Jackson D., Hossain M.J., Hickman D., Perez D.R., Lamb R.A. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 2008, 105(11):4381-4386.
81. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 2009, 106(9):3455-3460.
82. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443(7111):578-581.
83. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445(7125):319-323.
84. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4(8):e1000115.
85. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12(10):1203-1207.
86. Peiris J.S., Yu W.C., Leung C.W., Cheung C.Y., Ng W.F., Nicholls J.M., et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363(9409):617-619.
87. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360(9348):1831-1837.
88. Chen W., Calvo P.A., Malide D., Gibbs J., Schubert U., Bacik I., et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001, 7(12):1306-1312.
89. Zell R., Krumbholz A., Eitner A., Krieg R., Halbhuber K.J., Wutzler P. Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 2007, 88(Pt 2):536-546.
90. Zamarin D., Ortigoza M.B., Palese P., Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 2006, 80(16):7976-7983.
91. McAuley J.L., Hornung F., Boyd K.L., Smith A.M., McKeon R., Bennink J., et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007, 2(4):240-249.
92. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T., Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007, 3(10):1414-1421.
93. Gibbs J.S., Malide D., Hornung F., Bennink J.R., Yewdell J.W. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003, 77(13):7214-7224.
94. Zamarin D., Garcia-Sastre A., Xiao X., Wang R., Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005, 1(1):e4.
95. Mazur I., Anhlan D., Mitzner D., Wixler L., Schubert U., Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 2008, 10(5):1140-1152.
96. McAuley J.L., Zhang K., McCullers J.A. The effects of influenza A Virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 2010, 84(1):558-564.
97. Portela A., Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol 2002, 83(Pt 4):723-734.